Medications can affect hormone test results in 2 distinct ways, and the difference matters for every client ordering lab work through a direct-pay testing provider. Some drugs change the actual hormone level in the blood. Others leave the hormone untouched but distort the assay reading, producing a number that looks abnormal when the biology is normal. The Endocrine Society's 2018 testosterone guideline draws this line clearly: clinicians should not test for testosterone deficiency during short-term use of medicines that suppress testosterone, because those medicines create a temporary, reversible drop rather than a lasting endocrine problem (Bhasin et al., 2018).
A lab result is only as reliable as the context around it. Knowing which prescriptions, over-the-counter products, and supplements sit in the medicine cabinet before a blood draw is one of the simplest ways to avoid a misleading result and an unnecessary clinical workup.
Medication-related interference falls into a physiologic category (the drug changes the hormone) and an analytic category (the drug or supplement changes the assay signal). Both matter when ordering hormone and metabolic panels, and both are avoidable with a complete medication history.
How Do Opioids Affect Testosterone Levels?
Opioids suppress testosterone through the hypothalamic-pituitary-gonadal axis. The drug dampens GnRH pulses, LH falls, and testicular testosterone production follows. This is a real physiologic suppression, not an assay artifact.
A 2020 systematic review and meta-analysis covered 52 studies and 18,428 subjects. Within that review, 15 studies pooling 3,250 mostly male participants reported hypogonadism in 63% of chronic opioid users (95% CI 55-70%) (de Vries et al., 2020). Long-acting full agonists like methadone and extended-release oxycodone suppress more than shorter-acting agents. Buprenorphine suppresses less than methadone in comparative series.
The Endocrine Society released a scientific statement in October 2024 confirming that male hypogonadism is a well-recognized opioid effect, with under-recognized consequences for the adrenal axis and bone density (Karavitaki et al., 2024). The AUA guideline separately recommends measuring total testosterone in men on chronic narcotics even without classic deficiency symptoms (Mulhall et al., 2018).
Stopping or lowering the opioid dose may allow the axis to recover, though the timeline varies and is not precisely defined in the literature.
Do Glucocorticoids Change Hormone Panels?
High-dose glucocorticoids can cause secondary hypogonadism by suppressing GnRH and LH. They also suppress the cortisol axis, meaning a morning cortisol drawn during chronic prednisone use cannot be interpreted as a healthy HPA reading.
Morrison et al. (1994) measured testosterone in men on long-term oral prednisolone and found a mean 33% lower level compared to controls (14.5 nmol/L vs 21.7 nmol/L), with LH, FSH, and SHBG similar across groups (Morrison et al., 1994). Low-dose inhaled corticosteroids (200-800 mcg/day beclomethasone) did not produce a statistically meaningful reduction. The Endocrine Society lists high-dose glucocorticoids as both a testing indication and a reversible cause of secondary hypogonadism, meaning the low testosterone may resolve once the steroid dose drops.
Can Biotin Supplements Cause False Hormone Readings?
Biotin is among the most recognized causes of analytic (not physiologic) hormone test interference, and it is the one most often missed.
The FDA issued safety communications in 2017 and 2019 warning that biotin can distort results on immunoassay platforms that use biotin-streptavidin chemistry (FDA, 2017; updated 2019). Li et al. published a crossover study in JAMA with 6 healthy adults, showing that 10 mg/day of biotin for 7 days interfered with 9 of 23 biotinylated assays (39%) and 0 of 14 non-biotinylated assays (Li et al., 2017). The sample was small, but the findings prompted the FDA safety communications cited above.
The direction of error depends on assay design:
|
Assay Type |
Common Tests |
Direction of Error |
|
Competitive immunoassay |
Total testosterone, free T4, cortisol, estradiol (many platforms) |
Falsely high |
|
Sandwich immunoassay |
TSH, FSH, LH, prolactin, PSA, insulin (many platforms) |
Falsely low |
A man taking a 5,000-10,000 mcg biotin supplement (common in hair-and-nail formulas) can appear to have hyperthyroidism (low TSH, high free T4) and elevated testosterone on an immunoassay platform, while an LC-MS/MS testosterone measurement and a non-biotinylated TSH are normal. The recommended daily biotin intake is 30 mcg. Many supplements contain 166 to 333 times that amount.
Hold time before a blood draw is assay-specific. Some manufacturer inserts recommend at least 8 hours after doses above 5 mg. Peak interference occurs about 2 hours after ingestion. LC-MS/MS steroid methods do not use biotin-streptavidin chemistry and are not affected by this mechanism. Reporting current biotin use and dose to the ordering provider is the simplest precaution. Clients ordering individual biomarker tests should check whether their supplement stack includes biotin before scheduling a draw.
What About 5-Alpha-Reductase Inhibitors Like Finasteride?
Finasteride and dutasteride block conversion of testosterone to dihydrotestosterone (DHT). That is their intended purpose. The downstream lab effects are measurable.
Amory et al. (2007) reported that dutasteride 0.5 mg reduced serum DHT about 94% at 26-52 weeks, and finasteride 5 mg reduced DHT about 70-73% (Amory et al., 2007). A transient testosterone increase of about 25% appeared at 8 weeks, then settled to a smaller, non-statistically-meaningful elevation. A later meta-analysis of 11 studies (1,784 men) found a mean testosterone change of only +27 ng/dL (95% CI 1-54), which is not a large or consistent shift (Traish et al., 2018).
The lab trap most sources miss is PSA. 5-alpha-reductase inhibitors lower PSA by about 50%. FDA labeling and AUA BPH guidance require establishing a new PSA baseline after 6 months on the drug, or doubling the measured on-treatment PSA for clinical interpretation. A "normal" PSA while on finasteride can mask a value that would have flagged concern at twice the reading. Any client using finasteride or dutasteride should note it when ordering a PSA test or broader panel.
Do Antipsychotics Affect Hormone Levels?
Many antipsychotic medications raise prolactin by blocking dopamine D2 receptors on the lactotroph cells of the pituitary. Elevated prolactin then suppresses GnRH, followed by LH/FSH and testosterone. This is a real hormone change, not an assay artifact.
The strongest prolactin-raising effect comes from risperidone, paliperidone, and amisulpride, along with many first-generation agents. Quetiapine, clozapine, aripiprazole, and cariprazine have lower or prolactin-sparing profiles. Checking prolactin can help clarify whether a low testosterone result reflects the medication rather than primary or age-related hypogonadism in a man taking an antipsychotic.
How Do Anticonvulsants and SHBG Interact?
Enzyme-inducing anticonvulsants (phenytoin, carbamazepine, and some older agents) can raise sex hormone-binding globulin (SHBG). Because SHBG binds circulating testosterone, total testosterone can appear normal or even high while the free (unbound) testosterone that tissues actually use is low. The Endocrine Society's SHBG reference table lists anticonvulsants among known SHBG-raising exposures.
For clients on these medications, measuring both total testosterone and either free testosterone by equilibrium dialysis or SHBG gives a more complete picture than total testosterone alone.
Does Exogenous Testosterone Change the Panel?
This is the most common medication-related panel shift in the men's hormone testing channel. Exogenous testosterone (prescribed TRT, or prior anabolic-androgenic steroid use) suppresses hypothalamic GnRH, driving LH and FSH near the assay floor. The testosterone reading itself depends on dose, formulation, and time since the last administration.
LH and FSH near zero with a mid-range or high testosterone is the expected on-treatment pattern, not evidence of a pituitary tumor by itself. In one referral practice, Coward et al. (2013) found that prior anabolic steroid exposure was the most common cause of very low testosterone (below 50 ng/dL), accounting for 43% of those cases in that population (Coward et al., 2013). Reporting steroid history, whether from prescribed TRT or prior non-medical use, prevents an incorrect workup. A total testosterone test drawn without that context can point a provider in the wrong direction.
Do Statins Lower Testosterone?
The AHA's 2019 statin-safety scientific statement concluded that statins have minimal, if any, clinically meaningful effects on steroidogenesis (Newman et al., 2019). The Endocrine Society reviewed lovastatin, simvastatin, and pravastatin data and found no clinically relevant changes in cortisol, ACTH, total testosterone, free testosterone index, SHBG, LH, or FSH. A borderline testosterone result in a man taking a statin typically prompts review of body composition, sleep, opioid exposure, and illness history before the statin is considered a factor.
What to Report Before a Hormone Blood Draw
The most useful preparation step for accurate lab testing is a written list of every prescription, over-the-counter product, and supplement, including dose and timing. Marek Diagnostics has a separate guide on prepping for blood work that covers fasting, hydration, and draw timing; the medication list is the piece most clients skip.
Medications and supplements that belong on that disclosure include opioids (type, dose, duration), oral or injected glucocorticoids, finasteride or dutasteride, spironolactone, antipsychotics, anticonvulsants, biotin (exact dose in mcg), exogenous testosterone or anabolic steroids (current or past), estrogens, progestins, GnRH agonists or antagonists, and clomiphene or hCG.
Omitting a medication can distort the result in either direction. A false abnormal sends a client into an unnecessary workup. A false normal, like a thyroid panel that looks clean because high-dose biotin pushed TSH artifactually low, can hide real pathology. Because medications affect hormone test results through both physiologic and analytic pathways, a complete disclosure supports more accurate interpretation of every draw.
Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.
FAQs
Can medications affect my testosterone blood test?
Yes. The Endocrine Society's 2018 guideline names opioids and glucocorticoids as medications that suppress testosterone and advises against testing during short-term suppressive use. The AUA separately recommends measuring testosterone in men on chronic narcotics or chronic corticosteroids even without classic deficiency symptoms. These are real physiologic changes in the hormone, not assay errors.
How long should I stop biotin before a hormone blood draw?
Hold time depends on the assay platform and the biotin dose. The FDA warned in 2017 and 2019 that biotin can distort many immunoassays. Li et al. (JAMA, 2017) showed that 10 mg/day for 7 days interfered with 39% of biotinylated assays. Some manufacturer inserts recommend at least 8 hours after doses above 5 mg. Report the exact dose and timing to your ordering provider.
Does finasteride change my hormone results?
At the studied doses, finasteride can reduce serum DHT by about 70-73% and may raise testosterone transiently by about 25% early in treatment. The size of these shifts is dose-dependent. The larger clinical issue is PSA: 5-alpha-reductase inhibitors lower PSA by roughly 50%, so an on-treatment PSA reading needs to be doubled for accurate interpretation.
Will my statin affect a testosterone test?
The AHA's 2019 statin-safety statement found minimal, if any, clinically relevant effect on steroidogenesis. Do not hold a statin before a hormone blood draw. If testosterone is low, providers typically review body composition, sleep, opioid exposure, and illness before attributing the result to a statin.
Can antipsychotics cause low testosterone?
Yes. Dopamine D2-blocking antipsychotics (especially risperidone and paliperidone) raise prolactin, which then suppresses GnRH, LH, and testosterone. Checking prolactin can help clarify whether a low testosterone result reflects the medication rather than primary hypogonadism in a man taking these medications.
What is the difference between a real hormone change and a false lab reading?
A real (physiologic) change means the drug altered the hormone in the blood. The number is accurate, but the clinical context determines whether it represents a lasting problem or a temporary, reversible effect. A false (analytic) reading means the drug or supplement interfered with the assay chemistry without changing the hormone. Biotin is the most common cause of analytic interference on immunoassay platforms.
Should I stop all medications before lab work?
No. Many medications, including those for heart disease, seizures, and psychiatric conditions, should not be stopped without a provider's guidance. The goal is disclosure, not discontinuation. Bring a complete medication and supplement list so the provider can choose the right assay, adjust interpretation, or reschedule the draw if needed.
Share:
What Hormone Is High During Postpartum? A Lab Guide